Offerings

w

Professional Services

Iktos has a strong expertise in deep learning based de novo design for medicinal chemistry: superior technology, experience and skills, and technical infrastructure. In a relatively short time frame, we provide solutions that help to accelerate your research projects, from hit discovery to lead optimization, using ligand-based or structure-based approaches.

Research Collaborations & Partnerships

Your libraries and assays, our technology… to discover exciting and innovative compounds – deal terms to be discussed on a case-by-case basis.

Software / SaaS Licenses

We have developed Makya a SaaS application for AI-driven de novo design . We have also released Spaya, our computer-aided synthetic planning technology freely available here. If you are interested in assessing synthetic feasibility of thousands or even millions of molecules, contact us to try Spaya API.

SaaS platform for AI-driven new drug design focused on Multi-Parametric Optimization (MPO)

FIND OUT MORE

Discover and prioritize the best synthetic route to your compound using AI

FIND OUT MORE

Spaya retrosynthesis AI engine available through an API in a scalable infrastructure

FIND OUT MORE